The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 72 cents per share. The biotechnology firm posted revenue of ...

The Kansas City, Missouri-based company said it had profit of 34 cents per share. Earnings, adjusted for one-time gains and costs, came to 35 cents per share. The results missed Wall Street ...

Cullinan Therapeutics, Inc. (CGEM) on Thursday reported a loss of $47.6 million in its fourth quarter. The Cambridge, Massachusetts-based company ...

Equities researchers at Zacks Research raised their Q3 2025 earnings estimates for Pfizer in a report issued on Monday, February 24th. Zacks Research analyst K. Shah now forecasts that the ...

Analysts at Zacks Research dropped their Q2 2025 EPS estimates for shares of Woodward in a report issued on Monday, February ...

(ACRS) on Thursday reported a loss of $96.6 million in its fourth quarter. The Wayne, Pennsylvania-based company said it had a loss of $1.

NEW YORK CITY, NY / ACCESS Newswire / February 26, 2025 / Zacks Investment Research recently disclosed that it suffered a data breach that ...

The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.

Today's Research Daily features new research reports on 16 major stocks, including Alibaba Group Holding Limited (BABA), Pfizer Inc. (PFE) and MercadoLibre, Inc. (MELI), as well as a micro-cap stock ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), ...

A report by BleepingComputer cites a thread posted on an underground hacking forum claiming to have breached Zacks in June ...